CANCER RESEARCH UK
Cancer Research UK is dedicated to saving lives through research. Our mission is to prevent, control and cure cancer through our ground-breaking research and in the last 40 years our work has helped double survival rates. But there is more work to be done. The only charity fighting over 200 types of cancer, we rely on every pound donated to help get us closer to beating cancer.
Objects
THE OBJECTS FOR WHICH THE COMPANY IS ESTABLISHED ARE TO PROTECT AND PROMOTE THE HEALTH OF THE PUBLIC IN PARTICULAR BY RESEARCH INTO THE NATURE, CAUSES, DIAGNOSIS, PREVENTION, TREATMENT AND CURE OF ALL FORMS OF CANCER, INCLUDING THE DEVELOPMENT OF FINDINGS OF RESEARCH INTO PRACTICAL APPLICATIONS FOR THE PREVENTION, TREATMENT AND CURE OF CANCER AND IN FURTHERANCE OF THAT PRIMARY OBJECT, TO PROVIDE INFORMATION AND RAISE PUBLIC UNDERSTANDING OF SUCH MATTERS.
Financial health, per its FY2025 accounts
The accounts state that total income increased by 8% to £735m, driven largely by a £58m rise in legacy gifts. The charity maintains a strong liquidity position with £320m in managed cash and investments, representing approximately 5.2 months of cover against cash outgoings, which exceeds its policy minimum of three months.
What the accounts disclose
“The figures used to calculate the bandings above are inclusive of wages, salaries and benefits but exclusive of social security costs and employer pension contributions.” — page 86
“Our income from gifts in Wills continued to grow and accounted for nearly 40% of our total income. We received £288m from legacy gifts”
“22p used for fundraising”
“we revised our reserves requirement from a range of 3–5 months of our total outgoings to a minimum of three months.”
“The Charity provides grant funding to the Crick. For more details on the Group’s shareholding in the Crick, see note 14.”
“Professor Nic Jones is a trustee of the Institute of Cancer Research: Royal Cancer Hospital (the ICR). The Charity provides grant funding to the ICR.” — page 115
“The Charity provides grant funding to the Crick. For more details on the Group’s shareholding in the Crick, see note 14.”
“Professor Nic Jones is a trustee of the Institute of Cancer Research: Royal Cancer Hospital (the ICR). The Charity provides grant funding to the ICR.” — page 115
“The Charity provides grant funding to the Crick. For more details on the Group’s shareholding in the Crick, see note 14.”
“Professor Nic Jones is a trustee of the Institute of Cancer Research: Royal Cancer Hospital (the ICR). The Charity provides grant funding to the ICR.” — page 115
“The Charity provides grant funding to the Crick. For more details on the Group’s shareholding in the Crick, see note 14.”
“Professor Nic Jones is a trustee of the Institute of Cancer Research: Royal Cancer Hospital (the ICR). The Charity provides grant funding to the ICR.” — page 115
Year-over-year changes
- Employees paid over £60,000: 312 (FY2024) → 380 (FY2025).
- Reserves position vs the charity's own policy moved from "within" (FY2024) to "above" (FY2025).
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/03/2025
- Volunteers: 26,000
- Government income: £1,549,877 — contracts £6,325 (4), grants £1,543,552 (6); under 1% of the £734,753,802 total gross income on the same return
- Employees paid over £60,000: 380 (£60,001–£70,000: 166; £70,001–£80,000: 91; £80,001–£90,000: 52; £90,001–£100,000: 23; £100,001–£110,000: 11; £110,001–£120,000: 10; £120,001–£130,000: 5; £130,001–£140,000: 2; £140,001–£150,000: 1; £150,001–£200,000: 11; £200,001–£250,000: 5; £250,001–£300,000: 3)
- Trustee benefits, answered Yes to: any trustee benefit; other trustee benefit
- Has a trading subsidiary
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/03/2024
- Volunteers: 25,200
- Government income: £3,607,734 — contracts £28,650 (3), grants £3,579,084 (2); under 1% of the £684,207,447 total gross income on the same return
- Employees paid over £60,000: 312 (£60,001–£70,000: 139; £70,001–£80,000: 67; £80,001–£90,000: 48; £90,001–£100,000: 17; £100,001–£110,000: 12; £110,001–£120,000: 6; £120,001–£130,000: 5; £130,001–£140,000: 1; £140,001–£150,000: 3; £150,001–£200,000: 8; £200,001–£250,000: 4; £250,001–£300,000: 2)
- Has a trading subsidiary
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/03/2023
- Volunteers: 25,000
- Government income: £3,915,557 — contracts £2,700 (3), grants £3,912,857 (2); under 1% of the £718,793,137 total gross income on the same return
- Employees paid over £60,000: 261 (£60,001–£70,000: 93; £70,001–£80,000: 80; £80,001–£90,000: 35; £90,001–£100,000: 14; £100,001–£110,000: 9; £110,001–£120,000: 7; £120,001–£130,000: 6; £130,001–£140,000: 2; £140,001–£150,000: 3; £150,001–£200,000: 8; £200,001–£250,000: 3; £250,001–£300,000: 1)
- Has a trading subsidiary
- Grant-making is its main activity
UK research funding (UKRI Gateway to Research)
- Everything we (think we) know about Narrative CVs
- The Collaborative Computational Project for NMR (CCPN): Supporting biomolecular NMR and community driven NMR software development.
- Analysis of cis-acting RNA sequences required for intracellular localisation of gurken,the Drosophila TGF alpha homologu
- Automatic Binary Parallelisation
- Programme in Lipidomic Oncology
- Plasmon-enhanced spectroscopy and imaging inside cells
- New substrates and functions for the DYRK protein kinases
- A National Network for Applications of High-Field NMR in the Life and Physical Sciences
- the roleDefining of IL-1B in breast cancer bone metastasis
- Research and Training to create assets in the form of new companies to develop a new model to generate innovative therapies
Property (HM Land Registry)
Advertised salaries (public job ads)
- Clinical Data Manager
- Prospect Research Manager
- Retail Sunday Assistant
- Strategic Partnerships Insight Manager
- Strategic Partnerships Insight Manager
- Retail Saturday Assistant
- Retail Assistant Manager
- Training and Quality Coordinator
Structured financials (annual return, FY ending 31/03/2025)
Register events
- Received assets from another charity (10/11/2026)
- Received assets from another charity (10/11/2026)
- Received assets from another charity (23/06/2026)
- Received assets from another charity (30/03/2026)
- Received assets from another charity (14/02/2026)
- Received assets from another charity (24/04/2025)
Trustees
- Catherine Eve Smaje
- Dr Robert James Campbell Easton
- Hans Edgar Bishop
- Hitesh Thakrar
- Lord Simon Stevens
- Mark Philip Evans
- PROFESSOR GERARD IAN EVAN
- PROFESSOR PAMELA RENATE KEARNS PhD FRCPCH
- Professor Dame Nancy Jane Rothwell
- Professor Doreen Ann Cantrell FRS
- Professor Dr Reinier Harm Medema
- Professor Iain Alexander McNeish
- Rakshit Kapoor
- Sarah Whitney
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £734.8m | £714.7m |
| 31/03/2024 | £684.2m | £692.4m |
| 31/03/2023 | £718.8m | £640.8m |
| 31/03/2022 | £668.4m | £665.9m |
| 31/03/2021 | £582.1m | £570.6m |
Common questions
Is CANCER RESEARCH UK financially healthy?
Per its FY2025 accounts: The accounts state that total income increased by 8% to £735m, driven largely by a £58m rise in legacy gifts. The charity maintains a strong liquidity position with £320m in managed cash and investments, representing approximately 5.2 months of cover against cash outgoings, which exceeds its policy minimum of three months. Its FY2025 accounts were audited by PricewaterhouseCoopers LLP.
Who funds CANCER RESEARCH UK?
Funders whose own accounts filings name CANCER RESEARCH UK as a grant recipient include CHILDREN WITH CANCER UK, GREAT ORMOND STREET HOSPITAL CHILDREN'S CHARITY, The Hugh Mumford Charitable Trust, THE TANLAW FOUNDATION, THE EXILARCH'S FOUNDATION.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| CHILDREN WITH CANCER UK | FY2022 | £2.8m | Research into prevention and causes |
| GREAT ORMOND STREET HOSPITAL CHILDREN'S CHARITY | FY2023 | £1.3m | Research |
| Flat Iron Trust | FY2024 | Unverified read£1.0m | |
| The Hugh Mumford Charitable Trust | FY2025 | £1.0m | |
| THE TANLAW FOUNDATION | FY2023 | £1.0m | Medical and disability |
| THE EXILARCH'S FOUNDATION | FY2022 | £802k | Hospitals, Medical Education and Research |
| PRISM THE GIFT FUND | FY2021 | £755k | Grants to institutions/organisations |
| THE MASTER CHARITABLE TRUST | FY2022 | £644k | |
| DENISE COATES FOUNDATION | FY2025 | £593k | To support a three-year project testing and trialling a new vaccine to prevent ovarian cancer. |
| THE CATHERINE COOKSON CHARITABLE TRUST | FY2022 | £250k | Medical, Health and Sickness |
| THE TAYLOR FAMILY FOUNDATION | FY2023 | £250k | |
| OPTIGENE FOUNDATION | FY2025 | Unverified read£238k | |
| CRIS CANCER FOUNDATION | FY2025 | £201k | Lung Cancer Vaccine Development |
| THE PENNIES FOUNDATION | FY2025 | Unverified read£173k | Grant to institution |
| VEG TRUST INCORPORATING THE MATTHEW EYTON ANIMAL WELFARE TRUST | FY2023 | Unverified read£172k | Medical research |
| VEG TRUST INCORPORATING THE MATTHEW EYTON ANIMAL WELFARE TRUST | FY2023 | Unverified read£172k | Medical research |
| THE SCHRODER FOUNDATION | FY2023 | £150k | |
| THE PENNIES FOUNDATION | FY2021 | Unverified read£148k | Grant to institution |
| THE PENNIES FOUNDATION | FY2023 | Unverified read£147k | |
| THE JOAN LYNETTE DALTON CHARITABLE TRUST | FY2025 | Unverified read£143k | |
| SLIMMERS MAKING IT A LITTLE EASIER FOR SOMEONE | FY2023 | £142k | |
| Flat Iron Trust | FY2025 | £140k | |
| GREAT ORMOND STREET HOSPITAL CHILDREN'S CHARITY | FY2024 | £127k | Research |
| PEACOCK CHARITABLE TRUST | FY2021 | £120k | |
| PROSTATE CANCER RESEARCH | FY2022 | £112k | 177Lu-PSMA |
| THE ORR MACKINTOSH FOUNDATION LIMITED | FY2022 | Unverified read£110k | |
| THE ADA HILLARD CHARITABLE TRUST | FY2025 | £101k | |
| THE SCHRODER FOUNDATION | FY2022 | £100k | |
| THE ROAN CHARITABLE TRUST | FY2024 | £100k | Protect and promote health of the public by research into the nature, causes, diagnosis, prevention, treatment and cure of all forms of cancer |
| THE ROAN CHARITABLE TRUST | FY2026 | £100k | |
| THE ROAN CHARITABLE TRUST | FY2025 | £100k | |
| THE ROAN CHARITABLE TRUST | FY2021 | £100k | Protect and promote health of the public by research into the nature, causes, diagnosis, prevention, treatment and cure of all forms of cancer |
| THE VIOLET TRUST | FY2025 | £100k | |
| THE ROAN CHARITABLE TRUST | FY2023 | £100k | Protect and promote health of the public by research into the nature, causes, diagnosis, prevention, treatment and cure of all forms of cancer |
| THE SCHRODER FOUNDATION | FY2021 | £100k | |
| PEACOCK CHARITABLE TRUST | FY2025 | £95k | |
| PEACOCK CHARITABLE TRUST | FY2023 | £95k | |
| PEACOCK CHARITABLE TRUST | FY2024 | £95k | |
| THE PENNIES FOUNDATION | FY2024 | £94k | |
| DAVID LISTER CHARITABLE TRUST | FY2024 | £93k | |
| PROSTATE CANCER RESEARCH | FY2023 | £86k | AR-V Splicing |
| VEG TRUST INCORPORATING THE MATTHEW EYTON ANIMAL WELFARE TRUST | FY2023 | Unverified read£82k | Medical research |
| THE EXILARCH'S FOUNDATION | FY2021 | £81k | Hospitals, Medical Education and Research |
| PETER DUBENS FAMILY FOUNDATION | FY2023 | £80k | |
| PEACOCK CHARITABLE TRUST | FY2022 | £70k | |
| THE MITIE FOUNDATION | FY2024 | £64k | |
| VEG TRUST INCORPORATING THE MATTHEW EYTON ANIMAL WELFARE TRUST | FY2023 | Unverified read£63k | Medical research |
| VEG TRUST INCORPORATING THE MATTHEW EYTON ANIMAL WELFARE TRUST | FY2023 | Unverified read£63k | Medical research |
| VEG TRUST INCORPORATING THE MATTHEW EYTON ANIMAL WELFARE TRUST | FY2023 | Unverified read£60k | Medical research |
| VEG TRUST INCORPORATING THE MATTHEW EYTON ANIMAL WELFARE TRUST | FY2023 | Unverified read£60k | Medical research |
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| Community Foundation North East | 31/07/2025 | £1k | Grant to Cancer Research UK |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| SIR SAMUEL SCOTT OF YEWS TRUST | 3 | £27k |
| TOM AND SHEILA SPRINGER CHARITY | 2 | £55k |
| PHILIP KING CHARITABLE TRUST | 2 | £50k |
| BEEFY'S CHARITY FOUNDATION | 2 | £40k |
| THE ADINT CHARITABLE TRUST | 2 | £30k |
| FRAZER TRUST | 2 | £23k |
| THE WILL CHARITABLE TRUST | 2 | £20k |
| G M MORRISON CHARITABLE TRUST | 2 | £18k |
Charities like this
- Blood Cancer UK Research
- PROSTATE CANCER UK
- CANCER RESEARCH AND GENETICS UK
- BREAST CANCER UK LIMITED
- PROSTATE CANCER RESEARCH
- YORKSHIRE CANCER RESEARCH
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| CANCER RESEARCH UK | £734.8m | — | 380 | above | 22.0% | no doubt |
| Blood Cancer UK Research | £21.1m | — | — | unclear | — | no doubt |
| PROSTATE CANCER UK | £45.5m | — | — | above | — | no doubt |
| CANCER RESEARCH AND GENETICS UK | £128k | — | 0 | unclear | — | no doubt |
| BREAST CANCER UK LIMITED | £2.1m | — | 0 | above | 17.7% | no doubt |
| PROSTATE CANCER RESEARCH | £7.5m | £120,001 - £130,000 | — | unclear | 20.5% | no doubt |